OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
Giuseppe Floresta, Chiara Zagni, Davide Gentile, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3261-3261
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies
Alexandre Blanco-González, Alfonso Cabezón, Alejandro Seco-González, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 891-891
Open Access | Times Cited: 312

Artificial Intelligence in Medicine and Dentistry
Marin Vodanović, Marko Subašić, Denis Milošević, et al.
Acta Stomatologica Croatica (2023) Vol. 57, Iss. 1, pp. 70-84
Open Access | Times Cited: 52

Tribulations and future opportunities for artificial intelligence in precision medicine
Claudio Carini, Attila A. Seyhan
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 34

Recent Advances in Automated Structure-Based De Novo Drug Design
Yidan Tang, Rocco Moretti, Jens Meiler
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 6, pp. 1794-1805
Open Access | Times Cited: 26

Shaping the future of AI in healthcare through ethics and governance
Rabaï Bouderhem
Humanities and Social Sciences Communications (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 25

Neural Networks for the Detection of COVID-19 and Other Diseases: Prospects and Challenges
Muhammad Waqar Azeem, Shumaila Javaid, Ruhul Amin Khalil, et al.
Bioengineering (2023) Vol. 10, Iss. 7, pp. 850-850
Open Access | Times Cited: 21

Computational Protein Design for COVID-19 Research and Emerging Therapeutics
Parismita Kalita, Timir Tripathi, Aditya K. Padhi
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 602-613
Open Access | Times Cited: 15

Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
Matteo Pavan, Stefano Moro
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4401-4401
Open Access | Times Cited: 14

1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study
Vincenzo Patamia, Giuseppe Floresta, Chiara Zagni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1425-1425
Open Access | Times Cited: 13

Convergence of Data Science-AI-Green Chemistry-Affordable Medicine
Blais Rebecca, Krishan Kumar, S. Padmini, et al.
Advances in computational intelligence and robotics book series (2023), pp. 348-373
Closed Access | Times Cited: 13

Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Agyemang Kwasi Sampene, Fatuma Nyirenda
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5

Towards personalized vaccines
Davide Montin, Veronica Santilli, Alessandra Beni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update
Qazi Mohammad Sajid Jamal
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13564-13564
Open Access | Times Cited: 22

Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review
Kavya Singh, Navjeet Kaur, Ashish A. Prabhu
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 8, pp. 737-753
Closed Access | Times Cited: 4

A web-based artificial intelligence system for label-free virus classification and detection of cytopathic effects
Zeynep Akkutay-Yoldar, Mehmet Türkay Yoldar, Yiğit Burak Akkaş, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

A current review on the development of antimicrobial drugs from bioactive phytocompounds using artificial intelligence
Suvendu Ghosh, Vishal Singha, Sutapa Datta, et al.
MGM Journal of Medical Sciences (2025) Vol. 12, Iss. 1, pp. 155-165
Open Access

Advances in Pharmaceutical Oral Solid Dosage Forms
P. Saikiran, T. K. Arun Kumar, Shristi Arya, et al.
(2025), pp. 111-142
Closed Access

Artificial intelligence in vaccine research and development: an umbrella review
Rabie Adel El Arab, Mansour Alkhunaizi, Yousef N. Alhashem, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
Davide Gentile, Alessandro Coco, Vincenzo Patamia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10067-10067
Open Access | Times Cited: 16

Computer-Assisted Design of Peptide-Based Radiotracers
Vincenzo Patamia, Chiara Zagni, Ilaria Brullo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6856-6856
Open Access | Times Cited: 9

Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top